Cargando…
Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)
INTRODUCTION: In a study conducted by Annane, patients with septic shock and unresponsive to adrenocorticotropic hormone stimulation receiving low-dose steroid therapy had prolonged survival but not significantly improved 28-day mortality. The present study examines intravenous steroid use in PROWES...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297614/ https://www.ncbi.nlm.nih.gov/pubmed/16277711 http://dx.doi.org/10.1186/cc3778 |